Shl Telemedicine (CH:SHLTN) has released an update.
SHL Telemedicine Ltd., a leader in personal telemedicine solutions, has announced the successful approval of their Executive Officers and Directors’ Compensation Policy for the next three years during their Special General Meeting. The company, listed on both the SIX Swiss Exchange and the Nasdaq Stock Exchange, specializes in medical call center services and telemedicine devices for managing cardiovascular and related diseases. This approval marks a significant step in SHL’s corporate governance and strategic planning.
For further insights into CH:SHLTN stock, check out TipRanks’ Stock Analysis page.
